GAVANTE Trademark

Trademark Overview

On Tuesday, March 13, 2007, a trademark application was filed for GAVANTE with the United States Patent and Trademark Office. The USPTO has given the GAVANTE trademark a serial number of 77129539. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 14, 2013. This trademark is owned by Glaxo Group Limited. The GAVANTE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines
gavante

General Information

Serial Number77129539
Word MarkGAVANTE
Filing DateTuesday, March 13, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 14, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 22, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 16, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Monday, January 14, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 14, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 19, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 18, 2012EXTENSION 5 GRANTED
Tuesday, June 12, 2012EXTENSION 5 FILED
Tuesday, June 12, 2012TEAS EXTENSION RECEIVED
Friday, December 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 8, 2011EXTENSION 4 GRANTED
Monday, December 5, 2011EXTENSION 4 FILED
Monday, December 5, 2011TEAS EXTENSION RECEIVED
Wednesday, June 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 14, 2011EXTENSION 3 GRANTED
Thursday, June 9, 2011EXTENSION 3 FILED
Thursday, June 9, 2011TEAS EXTENSION RECEIVED
Saturday, October 30, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 29, 2010EXTENSION 2 GRANTED
Wednesday, October 20, 2010EXTENSION 2 FILED
Wednesday, October 20, 2010TEAS EXTENSION RECEIVED
Tuesday, June 15, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 14, 2010EXTENSION 1 GRANTED
Monday, May 24, 2010EXTENSION 1 FILED
Monday, June 14, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 24, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 15, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 22, 2009PUBLISHED FOR OPPOSITION
Wednesday, September 2, 2009NOTICE OF PUBLICATION
Monday, August 17, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 13, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 29, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, July 6, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 6, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 29, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, July 23, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, January 23, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, July 21, 2007NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, July 21, 2007LETTER OF SUSPENSION E-MAILED
Saturday, July 21, 2007SUSPENSION LETTER WRITTEN
Wednesday, July 18, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 18, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 18, 2007ASSIGNED TO LIE
Friday, June 29, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, June 24, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, June 24, 2007NON-FINAL ACTION E-MAILED
Sunday, June 24, 2007NON-FINAL ACTION WRITTEN
Saturday, June 23, 2007ASSIGNED TO EXAMINER
Friday, March 16, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

gavante treatment disorders diseases respiratory neurological gastrointestinal dysfunction ophthalmological hepatological hormonal